3 months ago
NBIX
AnalystsAndrew S. FeinAndrew S. Fein's Stock Forecasts
AnalystsAndrew S. Fein
Analyst Ranking
Top 14%
#729 out of 5264 analysts
Average Return
+14.9%
Win Rate
60%38 out of 63
Risk vs Reward
Poor
Good
Andrew S. Fein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Day One Biopharmaceuticals IncDAWN | +271.21% | $5.80 | $21.53 | 2025-08-05 - 2026-04-23 | Buy |
Palvella Therapeutics IncPVLA | +171.29% | $47.30 | $128.32 | 2025-08-14 - 2026-04-30 | Buy |
Palvella Therapeutics IncPVLA | +122.43% | $57.69 | $128.32 | 2025-09-24 - 2026-04-30 | Buy |
89bio IncETNB | +72.71% | $8.61 | $14.87 | 2025-09-03 - 2025-09-19 | Buy |
Savara IncSVRA | +72.37% | $3.04 | $5.24 | 2025-08-14 - 2026-04-30 | Buy |
Andrew S. Fein Analyst Color
Get additional color on Andrew S. Fein's coverage of popular stocks
5 months ago
BCRX
Andrew S. Fein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aura Biosciences IncAURA | 1 | Buy | $24.00 | +240.43% | Maintains | 3 days ago |
Protara Therapeutics IncTARA | 1 | Buy | $27.00 | +406.57% | Maintains | 3 days ago |
Wave Life Sciences LtdWVE | 4 | Buy | $18.00 | +154.96% | Maintains | 18 days ago |
Neurocrine Biosciences IncNBIX | 3 | Buy | $215.00 | +63.29% | Maintains | 25 days ago |
Biogen IncBIIB | 2 | Buy | $237.00 | +25.21% | Maintains | a month ago |
United Therapeutics CorpUTHR | 3 | Buy | $660.00 | +15.52% | Maintains | a month ago |
Metavia IncMTVA | 3 | Buy | $20.00 | +1,288.89% | Maintains | a month ago |
Insmed IncINSM | 4 | Buy | $245.00 | +79.71% | Maintains | a month ago |
Denali Therapeutics IncDNLI | 1 | Buy | $42.00 | +124.36% | Maintains | a month ago |
Amylyx Pharmaceuticals IncAMLX | 3 | Buy | $34.00 | +112.50% | Reiterates | a month ago |
Palvella Therapeutics IncPVLA | 6 | Buy | $270.00 | +110.41% | Maintains | a month ago |
Vertex Pharmaceuticals IncVRTX | 4 | Buy | $641.00 | +49.98% | Maintains | 2 months ago |
Liquidia CorpLQDA | 3 | Buy | $55.00 | +40.27% | Maintains | 2 months ago |
Savara IncSVRA | 3 | Buy | $10.00 | +90.84% | Maintains | 4 months ago |
Dbv Technologies SaDBVT | 3 | Buy | $40.00 | +90.48% | Maintains | 4 months ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Buy | $32.00 | +249.34% | Maintains | 5 months ago |
Kymera Therapeutics IncKYMR | 3 | Buy | $134.00 | +65.29% | Maintains | 5 months ago |
Kamada LtdKMDA | 1 | Buy | $13.00 | +59.71% | Maintains | 5 months ago |
Fulcrum Therapeutics IncFULC | 3 | Buy | $25.00 | +250.63% | Maintains | 5 months ago |
Madrigal Pharmaceuticals IncMDGL | 3 | Buy | $620.00 | +19.83% | Maintains | 5 months ago |
Arcturus Therapeutics Holdings IncARCT | 3 | Hold | $9.00 | +4.41% | Maintains | 6 months ago |
Prothena Corp Public Ltd CoPRTA | 3 | Buy | $30.00 | +171.25% | Maintains | 6 months ago |
Akero Therapeutics IncAKRO | 2 | Hold | $54.00 | -1.19% | Downgrades | 7 months ago |
89bio IncETNB | 2 | Hold | $14.50 | -2.29% | Downgrades | 7 months ago |
Terns Pharmaceuticals IncTERN | 1 | Hold | $7.44 | -85.94% | Assumes | 8 months ago |
Arvinas IncARVN | 1 | Buy | $18.00 | +81.82% | Maintains | 9 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Buy | $25.00 | +16.12% | Maintains | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.